Management of Retinitis Pigmentosa Via Wharton’s Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results

To investigate whether the natural progression rate of retinitis pigmentosa (RP) can be decreased with subtenon Wharton’s jelly-derived mesenchymal stem cell (WJ-MSC) application alone or combination with Magnovision. The study included prospective analysis of 130 eyes of 80 retinitis pigmentosa pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozmert, Emin, Arslan, Umut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Human Clinical Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552690/
https://www.ncbi.nlm.nih.gov/pubmed/37713598
http://dx.doi.org/10.1093/stcltm/szad051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552690/
https://www.ncbi.nlm.nih.gov/pubmed/37713598
http://dx.doi.org/10.1093/stcltm/szad051

Ejemplares similares